Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India · Delayed Price · Currency is INR 4,571.20
-1.00 (-0.02%)
Jun 12, 2026, 3:29 PM IST
Torrent Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Torrent Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹4,879. The average 1-year stock price forecast is 6.73% higher than the current stock price, while the lowest is ₹4,050 (-11.40%) and the highest is ₹5,423 (+18.63%).
Price Target: ₹4,879 (+6.73%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Torrent Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 16 | 16 | 15 | 16 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 6 | 6 | 5 | 5 | 6 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 27 | 28 | 28 | 28 | 28 |
Financial Forecast
Revenue This Year
189.57B
from 139.80B
Increased by 35.60%
Revenue Next Year
212.80B
from 189.57B
Increased by 12.26%
EPS This Year
69.75
from 65.88
Increased by 5.87%
EPS Next Year
94.76
from 69.75
Increased by 35.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 202.5B | ||
| Avg | 189.6B | ||
| Low | 149.6B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 44.9% | ||
| Avg | 35.6% | ||
| Low | 7.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 69.75 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 5.9% | ||
| Low | - |